Tag Archives: SNPS

Hot Stocks To Own For 2019

U.S. stocks fell sharply on Thursday, with major indexes suffering their worst day in weeks as the treat of a trade war with China sparked a widespread selloff.

Losses accelerated throughout afternoon trading, pushing the S&P 500 into negative territory for the year in a decline that showed signs of panic. Also weighing on sentiment was the latest policy statement by the Federal Reserve a day earlier, which raised questions about interest-rate policy; ongoing weakness at Facebook, which led the technology sector lower; and the resignation of President Donald Trump’s lead attorney, which added another element of political uncertainty for investors.

Hot Stocks To Own For 2019: Prudential Global Short Duration High Yield Fund, Inc.(GHY)

Advisors’ Opinion:

  • [By Logan Wallace]

    Vident Investment Advisory LLC lifted its position in PGIM Global Short Duration Hgh Yd Fd Inc (NYSE:GHY) by 2.9% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 594,728 shares of the company’s stock after acquiring an additional 16,908 shares during the quarter. Vident Investment Advisory LLC owned 1.45% of PGIM Global Short Duration Hgh Yd Fd worth $8,124,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Shares of NYSE:GHY opened at $13.99 on Wednesday. PGIM Global Short Duration Hgh Yd Fd Inc has a fifty-two week low of $12.60 and a fifty-two week high of $14.13.

    ILLEGAL ACTIVITY WARNING: “Camelot Portfolios LLC Buys Shares of 31,368 PGIM Global Short Duration Hgh Yd Fd Inc (GHY)” was first reported by Ticker Report and is owned by of Ticker Report. If you are reading this news story on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this news story can be viewed at www.tickerreport.com/banking-finance/4200826/camelot-portfolios-llc-buys-shares-of-31368-pgim-global-short-duration-hgh-yd-fd-inc-ghy.html.

    About PGIM Global Short Duration Hgh Yd Fd

Hot Stocks To Own For 2019: Tekla Healthcare Opportunies Fund(THQ)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Tekla Healthcare Opportunities Fund (NYSE:THQ) declared a monthly dividend on Monday, June 11th, Wall Street Journal reports. Investors of record on Wednesday, June 20th will be paid a dividend of 0.1125 per share on Friday, June 29th. This represents a $1.35 dividend on an annualized basis and a dividend yield of 7.72%. The ex-dividend date of this dividend is Tuesday, June 19th.

Hot Stocks To Own For 2019: Synopsys, Inc.(SNPS)

Advisors’ Opinion:

  • [By Max Byerly]

    Glenmede Trust Co. NA reduced its stake in Synopsys, Inc. (NASDAQ:SNPS) by 52.0% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 216,557 shares of the semiconductor company’s stock after selling 234,854 shares during the quarter. Glenmede Trust Co. NA owned about 0.15% of Synopsys worth $18,531,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    These are some of the news headlines that may have effected Accern Sentiment’s analysis:

    Get Synopsys alerts:

    Synopsys, Inc. (SNPS) Receives Average Rating of “Buy” from Brokerages (americanbankingnews.com) Free Research Report as Applied Materials’ Revenues Grew 28.8%; Adjusted EPS Surged 54.4% (finance.yahoo.com) Synopsys IC Validator Certified by Samsung Foundry for 7nm Signoff Physical Verification (prnewswire.com) Synopsys Fusion Technology Enables Lower Power, Smaller Area, and Higher Performance on Samsung Foundry 7LPP Process with EUV (prnewswire.com) Synopsys Announces New Release of LucidShape Software for Automotive Lighting Design and Analysis (finance.yahoo.com)

    A number of equities analysts recently commented on SNPS shares. KeyCorp reaffirmed an “overweight” rating and set a $110.00 price target (up from $106.00) on shares of Synopsys in a research note on Thursday, February 22nd. Royal Bank of Canada reaffirmed a “buy” rating on shares of Synopsys in a research note on Friday, February 23rd. Zacks Investment Research cut shares of Synopsys from a “hold” rating to a “strong sell” rating in a research note on Monday, February 26th. BidaskClub cut shares of Synopsys from a “hold” rating to a “sell” rating in a research note on Tuesday, February 27th. Finally, ValuEngine raised shares of Synopsys from a “hold” rating to a “buy” rating in a research report on Thursday, April 12th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. Synopsys presently has an average rating of “Buy” and an average target price of $102.71.

  • [By Joseph Griffin]

    Champlain Investment Partners LLC boosted its position in Synopsys, Inc. (NASDAQ:SNPS) by 3.9% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 686,287 shares of the semiconductor company’s stock after purchasing an additional 25,685 shares during the period. Champlain Investment Partners LLC owned about 0.46% of Synopsys worth $57,127,000 as of its most recent filing with the SEC.

  • [By Ethan Ryder]

    Royal London Asset Management Ltd. purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 60,026 shares of the semiconductor company’s stock, valued at approximately $5,137,000.

  • [By Motley Fool Staff]

    Synopsys (NASDAQ:SNPS) Q2 2018 Earnings Conference CallMay. 23, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Hot Stocks To Own For 2019: Edge Therapeutics, Inc.(EDGE)

Advisors’ Opinion:

  • [By Paul Ausick]

    Edge Therapeutics Inc. (NASDAQ: EDGE) dropped 14.5% Thursday to post a new 52-week low of $1.12. Shares closed at $1.31 on Wednesday and the stock’s 52-week high is $17.77. Volume was nearly 20 times the daily average of around 700,000 shares. The company on Wednesday ended a trial after reporting poor results and shares fell more than 90% on the news.

  • [By Logan Wallace]

    Media headlines about Edge Therapeutics (NASDAQ:EDGE) have been trending somewhat positive on Sunday, according to Accern. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Edge Therapeutics earned a media sentiment score of 0.02 on Accern’s scale. Accern also assigned media headlines about the biotechnology company an impact score of 42.6657723226264 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Logan Wallace]

    Edge Therapeutics (NASDAQ:EDGE) was upgraded by equities researchers at ValuEngine from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday.

  • [By Ethan Ryder]

    Edge Therapeutics Inc (NASDAQ:EDGE) shares were down 6.8% on Tuesday . The stock traded as low as $1.07 and last traded at $1.10. Approximately 1,087,000 shares changed hands during mid-day trading, a decline of 7% from the average daily volume of 1,164,140 shares. The stock had previously closed at $1.18.

  • [By Paul Ausick]

    Edge Therapeutics Inc. (NASDAQ: EDGE) dropped 92.6% Wednesday to post a new 52-week low of $1.15. Shares closed at $15.59 on Tuesday and the stock’s 52-week high is $17.77. Volume was nearly 300 times the daily average of around 160,000 shares. The company ended a trial after reporting poor results.

Top Tech Stocks To Invest In Right Now

Shares of Revolution Lighting Technologies Inc (NASDAQ:RVLT) saw strong trading volume on Thursday . 1,116,200 shares traded hands during trading, an increase of 478% from the previous session’s volume of 192,986 shares.The stock last traded at $2.63 and had previously closed at $2.20.

Separately, HC Wainwright set a $8.00 target price on shares of Revolution Lighting Technologies and gave the company a “buy” rating in a research note on Wednesday, May 2nd.

Get Revolution Lighting Technologies alerts:

The company has a current ratio of 2.00, a quick ratio of 1.28 and a debt-to-equity ratio of 0.67. The company has a market cap of $55.01 million, a PE ratio of -7.21 and a beta of 0.53.

Top Tech Stocks To Invest In Right Now: Ambarella, Inc.(AMBA)

Advisors’ Opinion:

  • [By Rick Munarriz]

    One of the few companies reporting this week is Ambarella (NASDAQ:AMBA). The provider of video chip solutions was a market darling when wearable action cameras were all the rage, but the stock has shed more than half its value since peaking three summers ago. 

  • [By Nicholas Rossolillo]

    It seems that anything these days with the words “autonomous driving” attached to it carries some level of controversy. Video chipmaker Ambarella (NASDAQ:AMBA) is no exception. But the thing is, the company isn’t really in that industry — at least not yet. Shares were hammered after the company reported on its first quarter, which ended April 30, because of further declines in its action camera (read GoPro) and drones business. So developing new chips for the future of transportation can’t come soon enough for Ambarella.

  • [By Chris Lange]

    Ambarella Inc. (NASDAQ: AMBA) also is scheduled to release its most recent quarterly results Thursday. The consensus forecast calls for $0.37 in EPS and $70.3 million in revenue. Shares closed at $48.89. The consensus price target is $57.50, and the 52-week range is $40.06 to $66.23.

  • [By Max Byerly]

    Engineers Gate Manager LP bought a new stake in shares of Ambarella Inc (NASDAQ:AMBA) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 89,677 shares of the semiconductor company’s stock, valued at approximately $3,462,000. Engineers Gate Manager LP owned approximately 0.27% of Ambarella as of its most recent filing with the Securities and Exchange Commission (SEC).

Top Tech Stocks To Invest In Right Now: Innodata Inc.(INOD)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Innodata (NASDAQ:INOD) will be releasing its Q1 2018 earnings data before the market opens on Tuesday, May 8th.

    Innodata (NASDAQ:INOD) last announced its earnings results on Thursday, March 8th. The technology company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $15.66 million for the quarter. Innodata had a negative return on equity of 10.94% and a negative net margin of 8.30%.

  • [By Stephan Byrd]

    Media coverage about Innodata (NASDAQ:INOD) has trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Innodata earned a media sentiment score of 0.10 on Accern’s scale. Accern also gave news articles about the technology company an impact score of 47.3485759085159 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

  • [By Logan Wallace]

    Luzich Partners LLC lifted its stake in shares of Innodata Inc (NASDAQ:INOD) by 4.9% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,316,550 shares of the technology company’s stock after acquiring an additional 61,944 shares during the period. Innodata accounts for approximately 1.5% of Luzich Partners LLC’s portfolio, making the stock its 12th biggest position. Luzich Partners LLC owned about 5.09% of Innodata worth $1,514,000 at the end of the most recent reporting period.

Top Tech Stocks To Invest In Right Now: Microsoft Corporation(MSFT)

Advisors’ Opinion:

  • [By Leo Sun]

    Microsoft (NASDAQ:MSFT) had a mixed second quarter based on last week’s earnings report. Its revenue rose 12% annually to $32.5 billion, but that marked its slowest growth in four quarters and missed expectations by $40 million. However, its non-GAAP net income rose 14% to $8.6 billion, as its EPS rose 15% to $1.10 per share — which beat estimates by a penny.

  • [By Natalie Walters]

    However, Alibaba is currently ranked as the third largest public cloud provider worldwide, behind Amazon.com (NASDAQ:AMZN) and Microsoft (NASDAQ:MSFT), according to research firm Gartner. Like Alibaba, Microsoft and Amazon both attributed a bulk of their revenue growth this past year to their respective cloud businesses.

  • [By Jeremy Bowman]

    Here are Amazon’s biggest competitors and their respective industries:

    Walmart (e-commerce, retail, grocery, India) Costco Wholesale (NASDAQ:COST) (retail, Amazon Prime) Target (NYSE:TGT) (retail, fast shipping) Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (product search, cloud computing, voice-activated technology) Microsoft (NASDAQ:MSFT) (cloud computing) eBay (e-commerce, marketplace) Netflix (NASDAQ:NFLX) (video streaming) Etsy (NASDAQ:ETSY) (e-commerce) UPS (NYSE:UPS) (logistics, delivery) FedEx (NYSE:FDX) (logistics, delivery)

    Below, we’ll examine each of the industries from which Amazon draws competitors and its closest rivals in each sector.

Top Tech Stocks To Invest In Right Now: Synopsys, Inc.(SNPS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Champlain Investment Partners LLC boosted its position in Synopsys, Inc. (NASDAQ:SNPS) by 3.9% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 686,287 shares of the semiconductor company’s stock after purchasing an additional 25,685 shares during the period. Champlain Investment Partners LLC owned about 0.46% of Synopsys worth $57,127,000 as of its most recent filing with the SEC.

  • [By Dan Caplinger]

    The stock market was generally quiet again on Thursday, with minimal moves lower for most major benchmarks. Once again, technology stocks helped to support the rest of the market, and the Nasdaq Composite outperformed most other stock indexes. New tariffs once again reminded investors of the threats on the trade front, although at least in the U.S., most economic data continue to support the idea of sustained growth for the foreseeable future. Some individual companies also had good news that lifted their shares. Advanced Micro Devices (NASDAQ:AMD), Synopsys (NASDAQ:SNPS), and FireEye (NASDAQ:FEYE) were among the best performers on the day. Here’s why they did so well.

  • [By Logan Wallace]

    Synopsys (NASDAQ:SNPS) had its price target raised by stock analysts at KeyCorp from $110.00 to $112.00 in a research report issued to clients and investors on Thursday. The firm currently has an “overweight” rating on the semiconductor company’s stock. KeyCorp’s price target would suggest a potential upside of 26.81% from the stock’s current price.

  • [By Max Byerly]

    Glenmede Trust Co. NA reduced its stake in Synopsys, Inc. (NASDAQ:SNPS) by 52.0% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 216,557 shares of the semiconductor company’s stock after selling 234,854 shares during the quarter. Glenmede Trust Co. NA owned about 0.15% of Synopsys worth $18,531,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    These are some of the news headlines that may have effected Accern Sentiment’s analysis:

    Get Synopsys alerts:

    Synopsys, Inc. (SNPS) Receives Average Rating of “Buy” from Brokerages (americanbankingnews.com) Free Research Report as Applied Materials’ Revenues Grew 28.8%; Adjusted EPS Surged 54.4% (finance.yahoo.com) Synopsys IC Validator Certified by Samsung Foundry for 7nm Signoff Physical Verification (prnewswire.com) Synopsys Fusion Technology Enables Lower Power, Smaller Area, and Higher Performance on Samsung Foundry 7LPP Process with EUV (prnewswire.com) Synopsys Announces New Release of LucidShape Software for Automotive Lighting Design and Analysis (finance.yahoo.com)

    A number of equities analysts recently commented on SNPS shares. KeyCorp reaffirmed an “overweight” rating and set a $110.00 price target (up from $106.00) on shares of Synopsys in a research note on Thursday, February 22nd. Royal Bank of Canada reaffirmed a “buy” rating on shares of Synopsys in a research note on Friday, February 23rd. Zacks Investment Research cut shares of Synopsys from a “hold” rating to a “strong sell” rating in a research note on Monday, February 26th. BidaskClub cut shares of Synopsys from a “hold” rating to a “sell” rating in a research note on Tuesday, February 27th. Finally, ValuEngine raised shares of Synopsys from a “hold” rating to a “buy” rating in a research report on Thursday, April 12th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. Synopsys presently has an average rating of “Buy” and an average target price of $102.71.

Top Tech Stocks To Invest In Right Now: RealPage, Inc.(RP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    JPMorgan Chase & Co. assumed coverage on shares of RealPage (NASDAQ:RP) in a research report released on Thursday, Marketbeat.com reports. The brokerage issued an overweight rating and a $76.00 price objective on the software maker’s stock.

  • [By Stephan Byrd]

    RealPage Inc (NASDAQ:RP) Chairman Stephen T. Winn sold 752,793 shares of the stock in a transaction on Thursday, June 7th. The shares were sold at an average price of $59.24, for a total value of $44,595,457.32. Following the completion of the transaction, the chairman now owns 1,945,439 shares in the company, valued at $115,247,806.36. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

  • [By Logan Wallace]

    Rothschild Asset Management Inc. decreased its stake in RealPage Inc (NASDAQ:RP) by 14.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 760,947 shares of the software maker’s stock after selling 126,009 shares during the period. Rothschild Asset Management Inc.’s holdings in RealPage were worth $41,928,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    Tyler Technologies (NASDAQ: RP) and RealPage (NASDAQ:RP) are both mid-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

  • [By Shane Hupp]

    CommerceHub (NASDAQ: CHUBK) and RealPage (NASDAQ:RP) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability and analyst recommendations.

Top 10 Warren Buffett Stocks To Watch For 2019

On May 15, I finally did something that I had hoped that I’d never do: I put in a market order in to sell the entirety of my stake in chip giant Intel (NASDAQ:INTC). Within an instant, a position that I’d started building in 2012 and added substantially to in 2013 was gone. 

Intel is a company that I wanted to own for Warren Buffett’s ideal holding period: forever. But, after careful consideration, I decided that this wasn’t a stock that I wanted in my portfolio any longer.

Image source: Intel.

Here’s why.

Some background

Although Intel’s financial execution over the last few years has been solid, deeper down the company’s technology execution has been quite poor.

To understand what I’m talking about when I say that Intel’s technology execution has been poor, I need to explain some basic concepts. 

A computer processor, such as the one that’s powering the device that you’re reading this on, is ultimately judged by the following criteria: 

Top 10 Warren Buffett Stocks To Watch For 2019: Ryerson Holding Corporation(RYI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday afternoon, the materials shares rose 0.49 percent. Meanwhile, top gainers in the sector included Ryerson Holding Corporation (NYSE: RYI), up 11 percent, and Synalloy Corporation (NASDAQ: SYNL) up 10 percent.

  • [By Lee Jackson]

    This top small-cap play could make sense for more aggressive accounts. Ryerson Holdings Inc. (NYSE: RYI) offers a line of stainless steel, aluminum, carbon steel and alloy steels, as well as nickel and red metals in various shapes and forms, including coils, sheets, rounds, hexagons, square and flat bars, plates, structurals and tubings.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Ryerson (RYI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Ryerson (RYI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lee Jackson]

    Ryerson
    This is a top small-cap play that could make sense for more aggressive accounts. Ryerson Holdings Inc. (NYSE: RYI) offers a line of stainless steel, aluminum, carbon steel and alloy steels, as well as nickel and red metals in various shapes and forms, including coils, sheets, square and flat bars, plates and tubing.

Top 10 Warren Buffett Stocks To Watch For 2019: AxoGen, Inc.(AXGN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    These are some of the media stories that may have impacted Accern’s analysis:

    Get AxoGen alerts:

    Analysts Anticipate AxoGen, Inc (AXGN) Will Announce Earnings of -$0.06 Per Share (americanbankingnews.com) The SVP Sales of AxoGen (NASDAQ: AXGN) is Selling Shares (analystratings.com) BRIEF-Axogen Inc Says On May 15, Board Elected CEO Zaderej To Succeed Grooms As Chairman (reuters.com) AxoGen, Inc (AXGN) SVP Shawn F. Mccarrey Sells 10,000 Shares (americanbankingnews.com) Global Nerve Repair Biomateria Market Report 2018-2023 -Axogen, Integra, Synovis, Collagen Matrix, Polyganics … (talkdailynews.com)

    AxoGen opened at $43.95 on Monday, Marketbeat reports. AxoGen has a fifty-two week low of $13.95 and a fifty-two week high of $46.00. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.81 and a current ratio of 3.32. The company has a market cap of $1.52 billion, a P/E ratio of -141.77 and a beta of -0.04.

  • [By Max Byerly]

    AxoGen, Inc Common Stock (NASDAQ:AXGN) – Investment analysts at Leerink Swann raised their FY2019 EPS estimates for shares of AxoGen, Inc Common Stock in a research report issued to clients and investors on Tuesday, August 21st. Leerink Swann analyst R. Newitter now forecasts that the medical equipment provider will earn ($0.39) per share for the year, up from their prior forecast of ($0.41). Leerink Swann currently has a “Outperform” rating and a $70.00 target price on the stock.

  • [By Shane Hupp]

    AxoGen, Inc (NASDAQ:AXGN) – Analysts at William Blair raised their Q2 2018 earnings estimates for AxoGen in a research report issued on Monday, May 14th. William Blair analyst K. Krum now expects that the medical equipment provider will post earnings per share of ($0.04) for the quarter, up from their prior forecast of ($0.05). William Blair currently has a “Outperform” rating on the stock. William Blair also issued estimates for AxoGen’s Q4 2018 earnings at ($0.03) EPS and FY2018 earnings at ($0.25) EPS.

  • [By Lee Jackson]

    Jefferies started coverage on this biotech/medical technology company with a Buy rating late last year. AxoGen Inc. (NASDAQ: AXGN) offers surgical solutions for peripheral nerve injuries. It provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane.

  • [By Ethan Ryder]

    Swiss National Bank lifted its stake in AxoGen, Inc Common Stock (NASDAQ:AXGN) by 5.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 52,200 shares of the medical equipment provider’s stock after purchasing an additional 2,800 shares during the period. Swiss National Bank owned about 0.14% of AxoGen, Inc Common Stock worth $2,623,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    State Board of Administration of Florida Retirement System boosted its holdings in AxoGen, Inc Common Stock (NASDAQ:AXGN) by 17.8% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 23,103 shares of the medical equipment provider’s stock after buying an additional 3,490 shares during the quarter. State Board of Administration of Florida Retirement System owned 0.06% of AxoGen, Inc Common Stock worth $1,161,000 at the end of the most recent quarter.

Top 10 Warren Buffett Stocks To Watch For 2019: Flushing Financial Corporation(FFIC)

Advisors’ Opinion:

  • [By Shane Hupp]

    BidaskClub downgraded shares of Flushing Financial (NASDAQ:FFIC) from a sell rating to a strong sell rating in a research note published on Saturday.

  • [By Stephan Byrd]

    Flushing Financial (NASDAQ:FFIC) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

    Fly Leasing (NYSE:FLY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $17.00 price target on the stock. According to Zacks, “Fly Leasing Limited, formerly known as Babcock & Brown Air Limited, is engaged in acquiring and leasing modern, high-demand and fuel-efficient commercial jet aircraft under long-term contracts to a diverse group of airlines throughout the world. The Company’s strategy is to effectively manage its fleet and grow its portfolio through accretive acquisitions of aircraft. FLY Leasing is managed and serviced by BBAM L.P., an aircraft leasing company. BBAM acts as manager of FLY Leasing and servicer of the aircraft portfolio under multi-year management and servicing agreements. In addition to arranging for the leasing of the fleet, BBAM assists in the acquiring and disposing of aircraft, marketeering aircraft for lease and release, collecting rents and other payments from the lessees of aircraft, monitoring maintenance, insurance and other obligations under leases, and enforcing FLY Leasing’s rights against lessees. BBAM is an independent company. FLY Leasing Limited is headquartered in Dublin, Ireland. “

  • [By Joseph Griffin]

    BidaskClub downgraded shares of Flushing Financial (NASDAQ:FFIC) from a sell rating to a strong sell rating in a research report released on Wednesday.

  • [By Shane Hupp]

    Flushing Financial (NASDAQ:FFIC) was upgraded by equities research analysts at ValuEngine from a “sell” rating to a “hold” rating in a note issued to investors on Friday.

  • [By Motley Fool Transcribers]

    Flushing Financial Corp  (NASDAQ:FFIC)Q4 2018 Earnings Conference CallFeb. 01, 2019, 9:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Warren Buffett Stocks To Watch For 2019: Synopsys, Inc.(SNPS)

Advisors’ Opinion:

  • [By Motley Fool Transcribing]

    Synopsys (NASDAQ:SNPS) Q3 2018 Earnings Conference CallAug. 22, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage gain ahead of the close was Synopsys, Inc. (NASDAQ: SNPS) which traded up over 6% at $100.70. The stock’s 52-week range is $77.91 to $101.76. Volume was about 4 million compared to the daily average volume of nearly 1 million.

  • [By Ethan Ryder]

    Royal London Asset Management Ltd. purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 60,026 shares of the semiconductor company’s stock, valued at approximately $5,137,000.

  • [By Motley Fool Staff]

    Synopsys (NASDAQ:SNPS) Q2 2018 Earnings Conference CallMay. 23, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Warren Buffett Stocks To Watch For 2019: Advance Auto Parts Inc(AAP)

Advisors’ Opinion:

  • [By Daniel Miller]

    Shares of Advanced Auto Parts (NYSE:AAP), a leading automotive aftermarket parts provider for professional installers and do-it-yourself consumers, are up 8% as of 3:25 p.m. EDT Tuesday after a strong second-quarter result. In fact, the company’s strong earnings result even boosted the share price of its competitors: AutoZone, Inc. (NYSE:AZO) popped more than 5% during early afternoon trading, and O’Reilly Automotive (NASDAQ:ORLY) also logged a smaller 3% gain.

  • [By Chris Lange]

    Advance Auto Parts Inc. (NYSE: AAP) is scheduled to share its quarterly report early on Tuesday. The consensus estimates are $1.85 in EPS on revenue of $2.27 billion. Shares were last seen trading at $146.35. The stock has a 52-week range of $78.81 to $148.70, and the consensus price target is $135.13.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday was Advance Auto Parts, Inc. (NYSE: AAP) which rose 4% to $114.21. The stock’s 52-week range is $78.81 to $158.59. Volume was nearly 2 million compared to the daily average volume of 1.5 million.

Top 10 Warren Buffett Stocks To Watch For 2019: VALE S.A.(VALE)

Advisors’ Opinion:

  • [By Chris Hill]

    Next up, the Justice Department has formally charged Huawei with a list of crimes that include stealing trade secrets from T-Mobile (NASDAQ:TMUS) as well as bank and wire fraud. And while China will have the telecom and smartphone giant’s back, there’s probably no way this ends well. Finally, after last week’s Brumadinho dam disaster, which spilled 3 million gallons of contaminated mining waste, destroyed a town, and killed at least 65 people in Brazil, Vale (NYSE:VALE) shareholders have to be asking themselves if the company is doomed.

  • [By Stephan Byrd]

    Shares of Vale SA (NYSE:VALE) gapped down before the market opened on Monday . The stock had previously closed at $13.11, but opened at $12.82. Vale shares last traded at $12.49, with a volume of 13924600 shares.

  • [By Neha Chamaria]

    Wheaton first took the gold leap in 2013 when it struck an agreement with mining giant Vale (NYSE:VALE) to buy 25% of the gold produced from its Salobo mine in Brazil for the life of mine, as well as 70% of the gold produced from its Sudbury mines in Canada for a 20-year term. Wheaton paid $1.9 billion to Vale in addition to stock warrants for the deal.

  • [By Logan Wallace]

    Brookfield Asset Management Inc. purchased a new position in shares of Vale SA (NYSE:VALE) in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 40,493 shares of the basic materials company’s stock, valued at approximately $515,000.

  • [By Reuben Gregg Brewer]

    In June Wheaton announced that it had purchased a cobalt stream from giant miner Vale S.A. (NYSE:VALE) for an up-front payment of $390 million. Starting in 2021 Wheaton will receive 42.4% of the Voisey’s Bay mine’s cobalt production until certain production targets are met, at which point it will receive half that amount. Wheaton’s cost will be pegged at 18% of the spot price for cobalt until certain financial targets are met, and will become 22% thereafter. Cobalt is a byproduct at this mine, which primarily produces nickel. Vale is using the cash to expand the mine, with a production ramp-up expected in 2021. 

Top 10 Warren Buffett Stocks To Watch For 2019: Galapagos NV(GLPG)

Advisors’ Opinion:

  • [By Stephen Mack]

    Our investing experts have made some tremendous picks over the last several years, outperforming the S&P 500 by 100%, 200%, or even as much as 700% in the case of Money Morning Executive Editor Bill Patalon’s 2012 pick of Galapagos NV (Nasdaq: GLPG).

  • [By Keith Speights]

    When it comes to treating cystic fibrosis (CF), you have Vertex Pharmaceuticals (NASDAQ:VRTX) and, well, that’s pretty much it. However, Galapagos (NASDAQ:GLPG) still hopes to challenge Vertex in the CF market in the not-too-distant future. The clinical-stage biotech also could soon have a big winner outside of the CF indication.

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    Around 44,000 CF patients have gene mutations that are addressable by Vertex’s current drugs. The company is moving forward with several late-stage studies of new triple-drug combinations that hold the potential to treat another 24,000 CF patients. While AbbVie (NYSE:ABBV) and Galapagos (NASDAQ:GLPG) are also developing triple-drug CF combos, Vertex has a clear head start.

Top 10 Warren Buffett Stocks To Watch For 2019: First Choice Healthcare Solutions, Inc. (FCHS)

Advisors’ Opinion:

  • [By Shane Hupp]

    First Choice Healthcare Solutions (OTCMKTS: FCHS) and Enzo Biochem (NYSE:ENZ) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

  • [By Shane Hupp]

    First Choice Healthcare Solutions (OTCMKTS: FCHS) is one of 21 public companies in the “Medical laboratories” industry, but how does it compare to its rivals? We will compare First Choice Healthcare Solutions to similar businesses based on the strength of its earnings, dividends, analyst recommendations, institutional ownership, profitability, valuation and risk.

  • [By Logan Wallace]

    First Choice Healthcare Solutions (OTCMKTS: FCHS) is one of 21 public companies in the “Medical laboratories” industry, but how does it contrast to its rivals? We will compare First Choice Healthcare Solutions to related businesses based on the strength of its risk, valuation, profitability, earnings, analyst recommendations, dividends and institutional ownership.

  • [By Max Byerly]

    First Choice Healthcare Solutions (OTCMKTS: FCHS) is one of 21 public companies in the “Medical laboratories” industry, but how does it compare to its peers? We will compare First Choice Healthcare Solutions to similar businesses based on the strength of its analyst recommendations, earnings, institutional ownership, profitability, risk, valuation and dividends.

  • [By Logan Wallace]

    First Choice Healthcare Solutions (OTCMKTS: FCHS) is one of 21 public companies in the “Medical laboratories” industry, but how does it contrast to its rivals? We will compare First Choice Healthcare Solutions to related businesses based on the strength of its risk, valuation, institutional ownership, earnings, profitability, dividends and analyst recommendations.

Top 10 Warren Buffett Stocks To Watch For 2019: GSE Systems, Inc.(GVP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    GSE Systems (NYSEAMERICAN:GVP) SVP Daniel Warren Pugh sold 4,400 shares of the business’s stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $3.75, for a total value of $16,500.00. Following the transaction, the senior vice president now owns 51,613 shares of the company’s stock, valued at approximately $193,548.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Top 10 Warren Buffett Stocks To Watch For 2019: Western Asset Mortgage Capital Corporation(WMC)

Advisors’ Opinion:

  • [By Max Byerly]

    ValuEngine lowered shares of Western Asset Mortgage Capit (NYSE:WMC) from a buy rating to a hold rating in a research report report published on Wednesday.

  • [By Stephan Byrd]

    Lincoln National Corp acquired a new position in Western Asset Mortgage Capital Corp (NYSE:WMC) during the 2nd quarter, Holdings Channel reports. The fund acquired 11,000 shares of the financial services provider’s stock, valued at approximately $115,000.

Best Casino Stocks To Watch Right Now

ValuEngine upgraded shares of Century Casinos (NASDAQ:CNTY) from a hold rating to a buy rating in a report issued on Thursday.

Several other research firms have also recently issued reports on CNTY. Zacks Investment Research raised shares of Century Casinos from a sell rating to a hold rating in a research note on Tuesday, January 30th. TheStreet cut shares of Century Casinos from a b rating to a c+ rating in a research note on Friday, April 6th. Finally, BidaskClub cut shares of Century Casinos from a hold rating to a sell rating in a research report on Tuesday, February 6th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. The company currently has a consensus rating of Hold and a consensus target price of $11.00.

Best Casino Stocks To Watch Right Now: AXT Inc(AXTI)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

    Get AXT alerts:

    Gallium Arsenide Global Market Players by 2023- Sumitomo Electric, AXT and China Crystal Technologies (newspharmaceuticals.com) TheStreet Downgrades AXT (AXTI) to C+ (americanbankingnews.com) Is this stock is Overbought? AXT, Inc. (AXTI) (stockquote.review) What Investors Should Know? AXT, Inc. (AXTI) (mostvolatilestocks.com) Community rallies around valley high school, putting on its first musical in 20 years (yourcentralvalley.com)

    Several analysts have recently issued reports on AXTI shares. BidaskClub upgraded AXT from a “hold” rating to a “buy” rating in a research note on Wednesday, February 14th. Dougherty & Co reiterated a “buy” rating on shares of AXT in a research note on Thursday, February 22nd. B. Riley decreased their price target on AXT from $8.75 to $8.25 and set a “neutral” rating for the company in a research note on Thursday, February 22nd. Zacks Investment Research downgraded AXT from a “buy” rating to a “hold” rating in a research note on Monday, January 1st. Finally, BWS Financial restated a “buy” rating on shares of AXT in a research note on Tuesday, April 17th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $10.44.

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares surged 115.8 percent to $4.3591. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) jumped 38.2 percent to $3.0251 after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Universal Corporation (NYSE: UVV) surged 26.7 percent to $61.40 after reporting fiscal Q4 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) rose 18.9 percent to $2.58.
    Evolus, Inc. (NASDAQ: EOLS) shares gained 17.8 percent to $22.8009.
    The Cato Corporation (NYSE: CATO) shares gained 17.5 percent to $21.07 after the company posted better-than-expected first-quarter results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.9 percent to $3.3613.
    Destination Maternity Corporation (NASDAQ: DEST) shares gained 15.5 percent to $3.35 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    AXT, Inc. (NASDAQ: AXTI) rose 15 percent to $7.65.
    nLIGHT, Inc. (NASDAQ: LASR) gained 14.5 percent to $34.27 following Q1 results.
    Achieve Life Sciences, Inc. (NASDAQ: ACHV) rose 14.3 percent to $11.4303.
    Bilibili Inc.. (NASDAQ: BILI) shares climbed 13.9 percent to $14.16 after announcing Q1 results.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) gained 13.2 percent to $2.91 after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    HUYA Inc. (NYSE: HUYA) gained 13.1
  • [By Logan Wallace]

    Texas Instruments (NASDAQ: TXN) and AXT (NASDAQ:AXTI) are both computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk.

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares climbed 154.95 percent to close at $5.15 on Thursday. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Tyme Technologies, Inc. (NASDAQ: TYME) jumped 33.45 percent to close at $3.87.
    Universal Corporation (NYSE: UVV) gained 29.72 percent to close at $62.85 after reporting fiscal Q4 results.
    Evolus, Inc. (NASDAQ: EOLS) shares rose 22.93 percent to close at $23.80.
    nLIGHT, Inc. (NASDAQ: LASR) jumped 21.52 percent to close at $36.37 following Q1 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) gained 20.28 percent to close at $2.61.
    The Cato Corporation (NYSE: CATO) shares rose 19.57 percent to close at $21.45 after the company posted better-than-expected first-quarter results.
    AXT, Inc. (NASDAQ: AXTI) gained 18.8 percent to close at $7.90.
    Catasys, Inc. (NASDAQ: CATS) rose 16.33 percent to close at $6.41.
    HUYA Inc. (NYSE: HUYA) rose 15.68 percent to close at $23.09 on Thursday.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) climbed 15.11 percent to close at $6.02 on Thursday after gaining 6.30 percent on Wednesday. Baird initiated coverage on Marinus Pharmaceuticals with an Outperform rating.
    Destination Maternity Corporation (NASDAQ: DEST) shares rose 14.48 percent to close at $3.32 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    China Rapid Finance Limited (NYSE: XRF) gained 11.53 percent to close at $3.29 after announcing preliminary Q1 results.
    Bilibili Inc.. (NASDAQ: BILI) shares rose 11.33 pe

Best Casino Stocks To Watch Right Now: Apollo Investment Corporation(AINV)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Income investors are always on the lookout for investments that will produce ample income, and it’s hard to find companies that do better right now than business development companies. BDCs like Main Street Capital (NYSE:MAIN) and Apollo Investment (NASDAQ:AINV) make investments in different types of businesses, often providing capital through either debt or equity financing. Because BDCs often elect the favorable tax status of regulated investment companies, they have to distribute the vast majority of their taxable income to their shareholders, and that produces the impressive yields that both Main Street and Apollo give their investors.

  • [By Shane Hupp]

    BidaskClub upgraded shares of Apollo Investment (NASDAQ:AINV) from a hold rating to a buy rating in a research report released on Monday morning.

    A number of other equities research analysts also recently commented on the company. TheStreet upgraded Apollo Investment from a c rating to a b- rating in a research report on Friday, June 8th. Zacks Investment Research upgraded Apollo Investment from a hold rating to a buy rating and set a $6.00 price objective for the company in a research report on Thursday, April 12th. ValuEngine downgraded Apollo Investment from a buy rating to a hold rating in a research report on Wednesday, February 28th. Finally, National Securities reiterated a neutral rating and set a $6.00 price objective on shares of Apollo Investment in a research report on Monday, May 21st. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has an average rating of Hold and a consensus target price of $6.34.

  • [By Logan Wallace]

    Apollo Investment (NASDAQ:AINV) will be posting its quarterly earnings results before the market opens on Friday, May 18th. Analysts expect Apollo Investment to post earnings of $0.16 per share for the quarter.

  • [By Motley Fool Staff]

    Apollo Investment Corporation (NASDAQ:AINV)Q4 2018 Earnings Conference CallMay 18, 2018, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Apollo Investment (NASDAQ:AINV)‘s stock had its “neutral” rating reiterated by investment analysts at National Securities in a research report issued to clients and investors on Monday. They presently have a $6.00 price target on the asset manager’s stock. National Securities’ target price indicates a potential upside of 6.19% from the stock’s current price.

Best Casino Stocks To Watch Right Now: Eaton Vance Floating Rate Income Trust(EFT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Relative Value Partners Group LLC grew its holdings in Eaton Vance Floating-Rate Income Trust (NYSE:EFT) by 11.0% in the first quarter, HoldingsChannel reports. The firm owned 799,864 shares of the investment management company’s stock after purchasing an additional 79,578 shares during the period. Relative Value Partners Group LLC’s holdings in Eaton Vance Floating-Rate Income Trust were worth $11,958,000 as of its most recent SEC filing.

Best Casino Stocks To Watch Right Now: Synopsys, Inc.(SNPS)

Advisors’ Opinion:

  • [By Logan Wallace]

    These are some of the news headlines that may have effected Accern Sentiment’s analysis:

    Get Synopsys alerts:

    Synopsys, Inc. (SNPS) Receives Average Rating of “Buy” from Brokerages (americanbankingnews.com) Free Research Report as Applied Materials Revenues Grew 28.8%; Adjusted EPS Surged 54.4% (finance.yahoo.com) Synopsys IC Validator Certified by Samsung Foundry for 7nm Signoff Physical Verification (prnewswire.com) Synopsys Fusion Technology Enables Lower Power, Smaller Area, and Higher Performance on Samsung Foundry 7LPP Process with EUV (prnewswire.com) Synopsys Announces New Release of LucidShape Software for Automotive Lighting Design and Analysis (finance.yahoo.com)

    A number of equities analysts recently commented on SNPS shares. KeyCorp reaffirmed an “overweight” rating and set a $110.00 price target (up from $106.00) on shares of Synopsys in a research note on Thursday, February 22nd. Royal Bank of Canada reaffirmed a “buy” rating on shares of Synopsys in a research note on Friday, February 23rd. Zacks Investment Research cut shares of Synopsys from a “hold” rating to a “strong sell” rating in a research note on Monday, February 26th. BidaskClub cut shares of Synopsys from a “hold” rating to a “sell” rating in a research note on Tuesday, February 27th. Finally, ValuEngine raised shares of Synopsys from a “hold” rating to a “buy” rating in a research report on Thursday, April 12th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. Synopsys presently has an average rating of “Buy” and an average target price of $102.71.

  • [By Logan Wallace]

    Synopsys (NASDAQ:SNPS) had its price target raised by stock analysts at KeyCorp from $110.00 to $112.00 in a research report issued to clients and investors on Thursday. The firm currently has an “overweight” rating on the semiconductor company’s stock. KeyCorp’s price target would suggest a potential upside of 26.81% from the stock’s current price.

  • [By Motley Fool Staff]

    Synopsys (NASDAQ:SNPS) Q2 2018 Earnings Conference CallMay. 23, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Champlain Investment Partners LLC boosted its position in Synopsys, Inc. (NASDAQ:SNPS) by 3.9% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 686,287 shares of the semiconductor company’s stock after purchasing an additional 25,685 shares during the period. Champlain Investment Partners LLC owned about 0.46% of Synopsys worth $57,127,000 as of its most recent filing with the SEC.

Best Casino Stocks To Watch Right Now: Tandy Leather Factory, Inc.(TLF)

Advisors’ Opinion:

  • [By Shane Hupp]

    Tandy Leather Factory (NASDAQ: TLF) and Vera Bradley (NASDAQ:VRA) are both small-cap retail/wholesale companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Best Casino Stocks To Watch Right Now: Achillion Pharmaceuticals Inc.(ACHN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.

  • [By Keith Speights]

    Skeptics might deride a comparison of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) as an exercise in finding the biggest loser. Both companies continue to post huge net losses every quarter, and their stocks are down by at least 30% over the last 12 months.

  • [By Stephan Byrd]

    Achillion Pharmaceuticals (NASDAQ:ACHN) has been given an average recommendation of “Hold” by the nine brokerages that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $5.20.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 29.4 percent to $5.50 in pre-market trading after the company disclosed that its first pivotal Phase 3 trial of IV tramadol achieved the primary and key secondary endpoints.
    MB Financial, Inc. (NASDAQ: MBFI) rose 16.8 percent to $51.00 in pre-market trading. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    LiveXLive Media, Inc. (NASDAQ: LIVX) rose 9.3 percent to $5.40 in pre-market trading after falling 28.92 percent on Friday.
    Celyad SA (NASDAQ: CYAD) shares rose 9 percent to $29.30 in pre-market trading after climbing 3.26 percent on Friday.
    Ethan Allen Interiors Inc. (NYSE: ETH) rose 6.7 percent to $26.40 in pre-market trading after gaining 1.64 percent on Friday.
    Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) rose 5.4 percent to $3.90 in pre-market trading after gaining 3.06 percent on Friday.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 5.2 percent to $34.70 in pre-market trading after gaining 1.38 percent on Friday.
    Westinghouse Air Brake Technologies Corporation (NYSE: WAB) rose 5.1 percent to $100 in pre-market trading. General Electric Company (NYSE: GE) agreed to merge its transportation unit with Wabtec.
    Sunrun Inc. (NASDAQ: RUN) shares rose 4.7 percent to $11.50 in pre-market trading.
    Nasdaq, Inc. (NASDAQ: NDAQ) shares rose 4.3 percent to $93.98 in the pre-market trading session.
    LaSalle Hotel Properties (NYSE: LHO) shares rose 4.2 percent to $33.25 in pre-market trading. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Monro, Inc. (NASDAQ: MNRO) shares rose 4 percent to $58.35 in pre-market trading as the company posted upbeat quarterly earnings and disclosed that it has acquired Free Service Tire.
    HUYA Inc. (NYSE: HUYA) rose 3.7 percent to $19.75 in pre-market trading after falling 4.80 percent on Friday.

    Find out what's going

Best China Stocks To Own For 2019

Wake up calls are never pleasant, but this one was particularly harsh: Over the course of just nine trading days in late January and early February, U.S. stocks dropped 10% as investors fretted over a government report showing higher than expected wage inflation. The plunge wiped out stock market gains for the year and chalked up one of the swiftest corrections in recent decades.

Investors tried to settle back into the dream world that dominated recent years, where stocks kept hitting new highs, volatility was at record lows and there was barely a hint of inflation. But the alarm bells kept ringing. In late March, fears of a trade war between the U.S. and China sent stocks skidding again. And while stocks plunged, the bonds that form the core of many retirees portfolios didnt live up to their safe-haven reputation. The Bloomberg Barclays U.S. Aggregate Bond index fell sharply during the stock market downturn and ended the first quarter down 1.5%.

Best China Stocks To Own For 2019: Synopsys, Inc.(SNPS)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Synopsys (NASDAQ:SNPS) Q2 2018 Earnings Conference CallMay. 23, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Champlain Investment Partners LLC boosted its position in Synopsys, Inc. (NASDAQ:SNPS) by 3.9% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 686,287 shares of the semiconductor company’s stock after purchasing an additional 25,685 shares during the period. Champlain Investment Partners LLC owned about 0.46% of Synopsys worth $57,127,000 as of its most recent filing with the SEC.

  • [By Logan Wallace]

    These are some of the news headlines that may have effected Accern Sentiment’s analysis:

    Get Synopsys alerts:

    Synopsys, Inc. (SNPS) Receives Average Rating of “Buy” from Brokerages (americanbankingnews.com) Free Research Report as Applied Materials Revenues Grew 28.8%; Adjusted EPS Surged 54.4% (finance.yahoo.com) Synopsys IC Validator Certified by Samsung Foundry for 7nm Signoff Physical Verification (prnewswire.com) Synopsys Fusion Technology Enables Lower Power, Smaller Area, and Higher Performance on Samsung Foundry 7LPP Process with EUV (prnewswire.com) Synopsys Announces New Release of LucidShape Software for Automotive Lighting Design and Analysis (finance.yahoo.com)

    A number of equities analysts recently commented on SNPS shares. KeyCorp reaffirmed an “overweight” rating and set a $110.00 price target (up from $106.00) on shares of Synopsys in a research note on Thursday, February 22nd. Royal Bank of Canada reaffirmed a “buy” rating on shares of Synopsys in a research note on Friday, February 23rd. Zacks Investment Research cut shares of Synopsys from a “hold” rating to a “strong sell” rating in a research note on Monday, February 26th. BidaskClub cut shares of Synopsys from a “hold” rating to a “sell” rating in a research note on Tuesday, February 27th. Finally, ValuEngine raised shares of Synopsys from a “hold” rating to a “buy” rating in a research report on Thursday, April 12th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. Synopsys presently has an average rating of “Buy” and an average target price of $102.71.

  • [By Logan Wallace]

    Synopsys (NASDAQ:SNPS) had its price target raised by stock analysts at KeyCorp from $110.00 to $112.00 in a research report issued to clients and investors on Thursday. The firm currently has an “overweight” rating on the semiconductor company’s stock. KeyCorp’s price target would suggest a potential upside of 26.81% from the stock’s current price.

Best China Stocks To Own For 2019: Jabil Circuit Inc.(JBL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Great West Life Assurance Co. Can reduced its holdings in shares of Jabil Inc (NYSE:JBL) by 2.9% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 146,625 shares of the technology company’s stock after selling 4,303 shares during the period. Great West Life Assurance Co. Can owned about 0.08% of Jabil worth $4,216,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Mackay Shields LLC acquired a new stake in Jabil (NYSE:JBL) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 743,100 shares of the technology company’s stock, valued at approximately $21,349,000.

  • [By Motley Fool Staff]

    Jabil (NYSE:JBL)Q3 2018 Earnings Conference CallJune 14, 2018, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Peter Graham]

    A long term performance chart shows shares of small cap Sanmina Corp (NASDAQ: SANM), a previous Elite Opportunity Pro (EOP) newsletter suggestion as the next breakout stock, andmid cap Flextronics International being bigger winners (albeit FLEX has steadily risen for two years while SANM has already peaked) compared with the moderately positive performance of mid cap Jabil Circuit, Inc (NYSE: JBL) and small cap Celestica Inc (NYSE: CLS):

Best China Stocks To Own For 2019: Basilea Pharmaceutica Ltd. (BPMUF)

Advisors’ Opinion:

  • [By ]

    Basilea Pharmaceuticals (OTC:BPMUF)

    BPMUF Is a Swiss company with commercialized products in the anti-infection space, but they are also working on agents in cancer research. One of these agents, BAL101553, is a prodrug of a so-called tumor checkpoint controller inhibitor, which destabilizes microtubules to disrupt dividing cells. This phase 1/2a study assessed the safety and the recommended dosage for this agent. The phase 1 portion of the trial recruited 20 patients to receive various doses of BAL101553.